Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest ROA

Below are the top small-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of return on assets.

The trailing-twelve-month return on assets at Hi Tech Pharmacal Co (NASDAQ: HITK) is 17.45%. Hi Tech Pharmacal's revenue for the same period is $230.00 million.

The trailing-twelve-month return on assets at Akorn (NASDAQ: AKRX) is 12.12%. Akorn's PEG ratio is 0.91.

The trailing-twelve-month return on assets at Par Pharmaceutical Companies (NYSE: PRX) is 10.74%. Par Pharmaceutical's operating margin for the same period is 18.40%.

The trailing-twelve-month return on assets at Medicis Pharmaceutical (NYSE: MRX) is 5.02%. Medicis Pharmaceutical's revenue for the same period is $763.68 million.